PI3K inhibitor dactolisib tosylate, Purity ≥98%

Cat. No.: X24-05-ZQ011

PI3K inhibitor dactolisib tosylate, Purity ≥98%

Synonym: 1028385-32-1; BEZ235 (Tosylate); NVP-BEZ 235 (Tosylate); PI3K inhibitor

  • CAS Number: 1028385-32-1
  • Compound CID: 49803145
Product Size
50 mg; 100 mg; 500 mg
Price
Datasheet
MSDS
Properties
Description
Dactolisib tosylate is a potent compound that inhibits PI3 kinase activity. It targets Autophagy, mTOR, mTORC1, mTORC2, p110α, p110α-E545K, p110α-H1047R, p110β, p110δ, and p110γ.
Molecular Weight
641.74
Molecular Formula
C37H31N5O4S
Targets
Autophagy; mTOR: 20.7 nM; mTORC1; mTORC2; p110α: 4 nM; p110α-E545K: 5.7 nM; p110α-H1047R: 4.6 nM; p110β: 75 nM; p110δ: 7 nM; p110γ: 5 nM
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Dactolisib tosylate can be used to study the dual inhibition of PI3K/mTOR in cancer and other proliferative disorders.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.